Meningococcal polysaccharide vaccine, groups A, C, Y and W-135 combined (MPSV4) Injectable Solution
RxNorm 347699

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 347699 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: meningococcal polysaccharide vaccine, groups A, C, Y and W-135 combined (MPSV4) Injectable Solution.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
Meningococcal group A polysaccharide 0.1 mg/ML / meningococcal group C polysaccharide 0.1 mg/ML / meningococcal polysaccharide vaccine group W-135 0.1 mg/ML / meningococcal polysaccharide vaccine group Y 0.1 mg/ML Injectable Solution
Primary clinical definition
AUI:12326796
View
PSN
Meningococcal polysaccharide vaccine, groups A, C, Y and W-135 combined (MPSV4) Injectable Solution
AUI:7271284
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCD

Semantic Clinical Drug (SCD):
Meningococcal group A polysaccharide 0.1 mg/ML / meningococcal group C polysaccharide 0.1 mg/ML / meningococcal polysaccharide vaccine group W-135 0.1 mg/ML / meningococcal polysaccharide vaccine group Y 0.1 mg/ML Injectable Solution
(Atom ID: 12326796)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / meningococcal polysaccharide vaccine group W-135 0.1 MG/ML / meningococcal polysaccharide vaccine group Y 0.1 MG/ML Injectable Solution
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
347699
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12326796
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
347699
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{328467} 29501
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{350965} 314724
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{350966} 314725
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{350967} 29503
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{328467} 29501
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{350965} 314724
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{350966} 314725
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{350967} 29503
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{328467} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{350965} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{350966} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{350967} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN OBSOLETED
01/30/2023
Date the RxNorm atom became obsolete
RXTERM FORM
Sol
The RxTerm dose form name for this drug
PSN

Prescribable Name (PSN):
Meningococcal polysaccharide vaccine, groups A, C, Y and W-135 combined (MPSV4) Injectable Solution
(Atom ID: 7271284)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
meningococcal polysaccharide vaccine, groups A, C, Y and W-135 combined (MPSV4) Injectable Solution
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
347699
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
7271284
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
347699
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Meningococcal ACWY Vaccines (MenACWY)


What is meningococcal disease? Meningococcal disease is a serious illness caused by a type of bacteria called Neisseria meningitidis. It can lead to meningitis (infection of the lining of the brain and spinal cord) and infections of the blood. Meningococcal disease often occurs without warning, even among people who are otherwise healthy. Meningococcal disease can spread from person to person through close contact (e.g., coughing, kissing) or lengthy contact, especially among people living in the same household. There are at least 12 types of N. meningitidis, called "serogroups." Serogroups A, B, C, W, and Y cause most meningococcal disease. Anyone can get meningococcal disease but certain people are at increased risk, including: Infants younger than one year old Adolescents and young adults 16 through 23 years old People with certain medical conditions that affect the immune system Microbiologists who routinely work with isolates of N. meningitidis People at risk because of a meningococcal outbreak in their community Even when it is treated, meningococcal disease kills 10 to 15 infected people out of 100. And of those who survive, about 10 to 20 out of every 100 will suffer disabilities such as hearing loss, brain damage, kidney damage, amputations, nervous system problems, or severe scars from skin grafts. Meningococcal ACWY vaccines can help prevent meningococcal disease caused by serogroups A, C, W, and Y. A different meningococcal vaccine is available to help protect against serogroup B.
[Learn More]


* Please review the disclaimer below.